Beruflich Dokumente
Kultur Dokumente
INTRODUCTION
CB-IMNCI is an integration of CB-IMCI and CB-NCP Programs as per the
decision of MOH on 2071/6/28 (October 14, 2015).
This integrated package of child-survival intervention addresses the major
problems of sick newborn such as birth asphyxia, bacterial infection,
jaundice, hypothermia, low birth-weight, counseling of breastfeeding.
It also maintains its aim to address major childhood illnesses like
Pneumonia, Diarrhea, Malaria, Measles and Malnutrition among under 5
year’s children in a holistic way.
In CB-IMNCI program, FCHVs are expected to carry out health promotional
activities for maternal, newborn and child health and dispensing of essential
commodities like distribution of iron, zinc, ORS, chlorhexidine which do not
require diagnostic skills, and immediate referral in case of any danger signs
appeared among sick newborn and children.
Health workers will counsel and provide the health services like
management of non-breathing cases, low birth weight babies, common
childhood illnesses, and management of neonatal sepsis.
Also, the program has provisioned for the post-natal visits by trained health
workers through primary health care outreach clinic.
GOALS OF CB-IMNCI
Improve newborn and child survival and healthy growth and development.
OBJECTIVES
To reduce neonatal morbidity and mortality by promoting essential newborn
care services
To reduce neonatal morbidity and mortality by managing major causes of
illness
To reduce morbidity and mortality by managing major causes of illness
among under 5 years children.
To reduce neonatal morbidity and mortality by promoting essential newborn
care services
To reduce neonatal morbidity and mortality by managing major causes of
illness
To reduce morbidity and mortality by managing major causes of illness
among under 5 years children.
TARGETS
Reduction of Under-five mortality rate (per 1,000 live births) to 28 by 2020
Reduction of Neonatal mortality rate (per 1,000 live births) to 17.5 by 2020
MAJOR INTERVENTION
Newborn Specific Interventions
Promotion of birth preparedness plan
Promotion of essential newborn care practice and postnatal care to mothers
and newborns
Identification and management of non-breathing babies at birth
Identification and management of preterm and low birth weight babies
Management of sepsis among young infants (0-59days) including diarrhea
Child Specific Interventions
Case management of children aged between 2-59 months for 5 major
childhood killer diseases
(Pneumonia, Diarrhoea, Malnutrition, Measles and Malaria)
Strategies
1. Quality of care through system strengthening and referral services for
specialized care
2. Ensure universal access to health care services for new born and young infant
3. Capacity building of frontline health workers and volunteers
4. Increase service utilization through demand generation activities
5. Promote decentralized and evidence-based planning and programming
VISION
CB-IMNCI vision to provide targeted services to 90% of the estimated
population by2020 as shown in the diagram below
APPROCHES
Assess a child
Classify a child’s illnesses
Identify treatments for the child.
Treatment instructions
counsel the mother to solve any feeding problems and her own health
When a child is brought back to the clinic give follow-up careand if
necessary, reassess the child for new problems
1.Assessment of child:
A child by checking first for danger signs, asking questions about common
conditions, examining the child, and checking nutrition and immunization
status.
Assessment includes checking the child for other health problems.
2. Classification of disease:
A child illness is classified using a color-coded triage system. Because many
children have more than one condition, each illness is classified according to
whether it requires:
-urgent pre-referral treatment and referral {red},
or
-Specific medical treatment and advice (yellow),
or
simple advice on home management (green).
3. Selection of treatment:
identify Specific treatments for the child.
If a child requires urgent referral, give essential treatment before the patient
is transferred.
If a child needs treatment at home, develop an integrated treatment plan for
the child and give the first dose of drugs in the clinic.
If a child should be immunized, give immunizations.
4. Health teaching/counselling:
Provide practical treatment instructions, including teaching the mother how
to give oral drugs, how to feed and give fluids during illness, and how to
treat local infections at home.
Give her health education and teach her hygienic practices.
Ask the caretaker to return for follow-up on specific date, and teach her how
to recognize signs that indicate the child should return
immediately to the health facility.
Assess feeding, including assessment of breastfeeding practices, and counsel
to solve any feeding problems found.
5. follow up services/visit
When a child is brought back to the clinic as requested, give follow-up care
and, if necessary, reassess the child for new problems.
DIARRHOEA
Diarrheal disease is the second leading cause of death in children under five
years old. It is both preventable and treatable.
Each year diarrhea kills around 525 000 children under five.
A significant proportion of diarrheal disease can be prevented through safe
drinking-water and adequate sanitation and hygiene.
Globally, there are nearly 1.7 billion cases of childhood diarrheal disease
every year.
Diarrhea is a leading cause of malnutrition in children under five years old.
Diarrhea is defined as the passage of three or more loose or liquid stools per
day (or more frequent passage than is normal for the individual). Frequent
passing of formed stools is not diarrhea, nor is the passing of loose, "pasty"
stools by breastfed babies.
PLAN A – TREATMENT AT HOME
GENTAMYCINDOSAGE
AGE/WEIGHT CIPROFLOXACIN
( TWICE A DAY FOR 3 DAYS)
TABLET-250 mg
6 month-5 years 1
Vitamin A dosage
For persistent diarrhoea
1 years 1 capsule
-5 years
FOLLOW UP
Persistent diarrhea : after 5 days
Ask mother:
Has diarrhea stopped?
Frequecy of diarrhea?
TREATMENT:
• If the diarrhea has not stopped ( if the child passes loose stool3 or more than
3 times a day ) , reassess the child. Treat the needful and refer to the hospital
• If the diarrhea has stopped ( if the child passes loose stool less than 3 times a
day) , instruct the mother to feed her baby as usual
AMOXICILLIN
TWICE A DAY FOR 5 DAYS
6-12months(6-8KG) 1 10 ml
AGE DOSAGE ; 2 MG
FOLLOW UP
Pneumonia
In 3rd day
Assess the danger signs
Assess if the child has difficulty in breathing
count breathing rate
Auscultate stridor/wheezing
Has the fever reduced
Treatment:
If stridor/wheezing persist along with other danger signs, give
ampicillin/gentamycin and refer to the hospital
If child has not improved , refer him to the hospital if the child had measles
within 3 months ,refer him)
If the child has improved, ask to continue the antibiotics
DOSAGE OF AMPICILLIN AND GENTAMYCIN
MALNUTRITION
Malnutrition refers to deficiencies, excesses, or imbalances in a person’s
intake of energy and/or nutrients. The term malnutrition addresses 3 broad
groups of conditions:
Undernutrition: which includes wasting (low weight-for-height), stunting
(low height-for-age) and underweight (low weight-for-age);
micronutrient-related malnutrition: which includes micronutrient
deficiencies (a lack of important vitamins and minerals) or micronutrient
excess; and
Overweight: obesity and diet-related noncommunicable diseases (such as
heart disease, stroke, diabetes).
Scope of the problem
In 2016, an estimated 155 million children under the age of 5 years were
suffering from stunting, while 41 million were overweight or obese.
Around 45% of deaths among children under 5 years of age are linked to
undernutrition. These mostly occur in low- and middle-income countries. At
the same time, in these same countries, rates of childhood overweight and
obesity are rising.
Who is at risk?
Every country in the world is affected by one or more forms of malnutrition.
Combating malnutrition in all its forms is one of the greatest global health
challenges.
Infants, children are at particular risk of malnutrition
Poverty amplifies the risk of, and risks from, malnutrition. People who are
poor are more likely to be affected by different forms of malnutrition. Also,
malnutrition increases health care costs, reduces productivity and slows
economic growth, which can perpetuate a cycle of poverty and ill health.
ANEMIA
Anemia is a condition in which the number of red blood cells or their oygen-
carrying capacity is insufficient to meet physiologic needs, Iron deficiency is
thought to be the most common cause of anemia globally, although other
conditions, such as folate, vitamin B12, parasitic infections, can cause
anemia.
VITAMIN A DOSE- FOR 6 MONTHS AND ABOVE\
IRON DOSE
OD for 14 days
4-12months(6-10kg) 1.5 ml
1-3 years(10-14kg) 2 ml
ALBENDAZOLE
If the child has not received Albendazole from past 6 months ,give him 4oo
mg of albendazole .
If the child is 1-2 years give him half tablet i.e (200mg)and if the child is
above 2 years give him 400 mg of tablet.
FOLLOW UP FOR ANEMIA
AFTER 14 DAYS
Give iron tablet. Instruct mother to come back to the health post and collect
iron tablets in 14 days.
Give iron tablets every 14 days for 2 months
If the pallor did not reduce, refer to the hospital
MALARIA
Malaria is a life-threatening disease caused by parasites that are transmitted
to people through the bites of infected female Anopheles mosquitoes. It is
preventable and curable.
Malaria is caused by Plasmodium parasites. The parasites are spread to
people through the bites of infected female Anopheles mosquitoes, called
"malaria vectors." There are 5 parasite species that cause malaria in humans,
and 2 of these species – P. falciparum and P. vivax – pose the greatest threat.
In 2017, there were an estimated 219 million cases of malaria in 87
countries.
The estimated number of malaria deaths stood at 435 000 in 2017
TRANSMISSION
In most cases, malaria is transmitted through the bites of female Anopheles
mosquitoes
INCUBATION PERIOD
The duration of the incubation period varies with the species of the parasite,
and in natural infections (in mosquito-transmitted malaria) this is
12 (9-14) days for falciparum malaria,
14 (8-17) days for vivax malaria,
17 (16-18) days for ovale malaria
CLINICAL FEATURES
COLD STAGE : The onset is with lassitude, headache, nausea and chilly
sensation followed in an hour or so by rigors. The temperature rises rapidly
to 39-41°C. Headache is often severe and commonly there is vomiting.
In early part of this stage, skin feels cold; later it becomes hot. Parasites are
usually demonstrable in the blood. The pulse is rapid and may be weak. This
stage lasts for 1/4-1 hour.
HOT STAGE : The patient feels burning hot and casts off his clothes. The
skin is hot and dry to touch. Headache is intense but nausea commonly
diminishes. The pulse is full and respiration rapid. This stage lasts for 2 to 6
hours.
SWEATING STAGE : Fever comes down with profuse sweating. The
temperature drops rapidly to normal and skin is cool and moist. The pulse
rate becomes slower, patient feels relieved and often falls asleep. This stage
lasts for 2-4 hours.
TREATMENT
MEDICINES
1. SEVERE COMPLICATED MALARIA
Artemisinin Suppository (Artesurate Single dose)
1 7.5 ml 15ml
2 7.5 ml 15ml
3 7.5 ml 7.5 ml